Stock CTKB CYTEK BIOSCIENCES, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Other languages Cytek Biosciences, Inc.

Equities

CTKB

US23285D1090

Market Closed - Nasdaq
Other stock markets
 16:00:00 2024-06-21 EDT 		5-day change 1st Jan Change
5.73 USD +5.14% Intraday chart for Cytek Biosciences, Inc. +1.96% -37.17%
06-12 Cytek Biosciences to Seek M&A CI
06-12 Transcript : Cytek Biosciences, Inc. Presents at Goldman Sachs 45th Annual Global Healthcare Conference, Jun-12-2024 09:20 AM

Other languages

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Cytek Biosciences to Seek M&A
Cytek Biosciences Board Approves $50 Million Share Buyback Plan
Cytek Biosciences, Inc. announces an Equity Buyback for $50 million worth of its shares.
Cytek Biosciences, Inc. authorizes a Buyback Plan.
Sector Update: Health Care Stocks Lean Lower Premarket Wednesday
Cytek Biosciences, Inc. Adds Ability to Detect Subcellular Particles to Its Cell Analysis Systems
Cytek Biosciences, Inc. Reaffirms Earnings Guidance for the Year Ending December 31, 2024
Cytek Biosciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
Cytek Biosciences Insider Sold Shares Worth $269,600, According to a Recent SEC Filing
Cytek Biosciences Appoints William McCombe as CFO, Reaffirms 2024 Guidance
Cytek Biosciences, Inc. Announces Appointment of Patrik Jeanmonod as Head of Corporate Development Analytics
Cytek Biosciences Unveils New Manufacturing Facility in Wuxi, China
Cytek Biosciences, Inc. Opens A New 50,000-Square-Foot Facility in Wuxi, China
Cytek Biosciences, Inc. Provides Earnings Guidance for the Year Ended December 31, 2024
Cytek Biosciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
Cytek Biosciences Agrees to Flow Cytometry Collaboration With Centre for Genomic Regulation, Pompeu Fabra University
Cytek Biosciences, Inc. Signs Agreement with CRG and UPF to Accelerate Scientific Discoveries
Cytek Seeks Merger and Acquisitions
Cytek Biosciences, Inc. Provides Revenue Guidance for the Year 2023
Cytek Biosciences Introduces the Cytek Orion? Reagent Cocktail Preparation System, the First-of-its-Kind Automated Cocktail Preparation Instrument for Flow Cytometry
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. CTKB Stock
  4. News Cytek Biosciences, Inc.
  5. Other languages